| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parkinson Disease | 87 | 2024 | 2877 | 7.810 |
Why?
|
| Dopamine | 87 | 2018 | 1607 | 6.360 |
Why?
|
| Brain Tissue Transplantation | 38 | 2011 | 81 | 6.200 |
Why?
|
| Fetal Tissue Transplantation | 39 | 2016 | 138 | 5.620 |
Why?
|
| Mesencephalon | 36 | 2016 | 332 | 4.210 |
Why?
|
| Glucosylceramidase | 11 | 2023 | 127 | 4.180 |
Why?
|
| Neurons | 108 | 2024 | 9463 | 3.780 |
Why?
|
| Corpus Striatum | 68 | 2016 | 1235 | 3.560 |
Why?
|
| Substantia Nigra | 33 | 2020 | 350 | 3.540 |
Why?
|
| Stem Cell Transplantation | 29 | 2015 | 1600 | 2.950 |
Why?
|
| Nerve Degeneration | 28 | 2019 | 748 | 2.850 |
Why?
|
| Parkinsonian Disorders | 14 | 2013 | 284 | 2.730 |
Why?
|
| Embryonic Stem Cells | 16 | 2013 | 1263 | 2.170 |
Why?
|
| alpha-Synuclein | 15 | 2023 | 750 | 2.070 |
Why?
|
| Lysosomes | 11 | 2023 | 924 | 2.020 |
Why?
|
| Induced Pluripotent Stem Cells | 13 | 2023 | 1860 | 1.950 |
Why?
|
| Huntington Disease | 28 | 2016 | 1144 | 1.890 |
Why?
|
| Nerve Growth Factors | 19 | 2008 | 564 | 1.740 |
Why?
|
| Stem Cells | 25 | 2014 | 3524 | 1.460 |
Why?
|
| Rats | 130 | 2020 | 23741 | 1.440 |
Why?
|
| Rats, Sprague-Dawley | 66 | 2020 | 8181 | 1.410 |
Why?
|
| Parkinson Disease, Secondary | 9 | 2015 | 122 | 1.290 |
Why?
|
| Axons | 13 | 2015 | 1674 | 1.260 |
Why?
|
| Cell Differentiation | 42 | 2019 | 11530 | 1.210 |
Why?
|
| Amyloid beta-Protein Precursor | 10 | 2010 | 1111 | 1.210 |
Why?
|
| Neurites | 7 | 2018 | 391 | 1.200 |
Why?
|
| Pluripotent Stem Cells | 11 | 2019 | 799 | 1.200 |
Why?
|
| Fibroblasts | 16 | 2021 | 4142 | 1.170 |
Why?
|
| Neurodegenerative Diseases | 8 | 2015 | 1088 | 1.160 |
Why?
|
| Tyrosine 3-Monooxygenase | 27 | 2016 | 370 | 1.140 |
Why?
|
| Animals | 239 | 2024 | 168475 | 1.120 |
Why?
|
| Nerve Tissue Proteins | 25 | 2008 | 4415 | 1.110 |
Why?
|
| Dyskinesia, Drug-Induced | 5 | 2016 | 165 | 1.090 |
Why?
|
| Brain | 54 | 2024 | 27121 | 1.030 |
Why?
|
| Motor Neurons | 4 | 2017 | 870 | 0.910 |
Why?
|
| Oxidopamine | 18 | 2015 | 172 | 0.890 |
Why?
|
| Glycolipids | 2 | 2023 | 206 | 0.890 |
Why?
|
| Transplantation, Heterologous | 19 | 2008 | 2386 | 0.880 |
Why?
|
| Toll-Like Receptor 3 | 3 | 2023 | 98 | 0.880 |
Why?
|
| Disease Models, Animal | 49 | 2020 | 18255 | 0.840 |
Why?
|
| Neostriatum | 10 | 2014 | 247 | 0.800 |
Why?
|
| Presynaptic Terminals | 4 | 2009 | 302 | 0.790 |
Why?
|
| Graft Survival | 27 | 2009 | 3820 | 0.790 |
Why?
|
| Levodopa | 5 | 2016 | 221 | 0.780 |
Why?
|
| Proteasome Endopeptidase Complex | 9 | 2016 | 1321 | 0.770 |
Why?
|
| Nerve Regeneration | 12 | 2015 | 795 | 0.770 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 8 | 2015 | 42 | 0.740 |
Why?
|
| Macaca fascicularis | 14 | 2015 | 903 | 0.730 |
Why?
|
| Receptors, Scavenger | 1 | 2021 | 123 | 0.720 |
Why?
|
| Dopamine Agents | 8 | 2007 | 189 | 0.700 |
Why?
|
| Synapses | 8 | 2014 | 1769 | 0.680 |
Why?
|
| Behavior, Animal | 22 | 2014 | 1878 | 0.670 |
Why?
|
| MPTP Poisoning | 6 | 2016 | 37 | 0.640 |
Why?
|
| Glycosphingolipids | 2 | 2021 | 73 | 0.640 |
Why?
|
| Motor Neuron Disease | 2 | 2010 | 97 | 0.620 |
Why?
|
| Insulin-Like Growth Factor II | 2 | 2017 | 269 | 0.610 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 5 | 2010 | 34 | 0.600 |
Why?
|
| Ubiquitin | 4 | 2014 | 839 | 0.600 |
Why?
|
| Microglia | 6 | 2020 | 1362 | 0.590 |
Why?
|
| Cholinergic Fibers | 9 | 2003 | 69 | 0.590 |
Why?
|
| Down Syndrome | 5 | 2010 | 901 | 0.590 |
Why?
|
| Antiparkinson Agents | 4 | 2016 | 184 | 0.590 |
Why?
|
| Putamen | 12 | 2016 | 292 | 0.590 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 9 | 2009 | 89 | 0.580 |
Why?
|
| Dependovirus | 4 | 2015 | 718 | 0.560 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2017 | 103 | 0.550 |
Why?
|
| Vesicular Monoamine Transport Proteins | 3 | 2016 | 32 | 0.550 |
Why?
|
| Hippocampus | 15 | 2005 | 3766 | 0.540 |
Why?
|
| Transforming Growth Factor alpha | 2 | 2008 | 135 | 0.540 |
Why?
|
| Mitochondrial Diseases | 1 | 2020 | 343 | 0.540 |
Why?
|
| Tomography, Emission-Computed | 13 | 2003 | 1122 | 0.530 |
Why?
|
| Embryo, Mammalian | 12 | 2007 | 1674 | 0.530 |
Why?
|
| Immunophilins | 3 | 2001 | 20 | 0.530 |
Why?
|
| Inclusion Bodies | 5 | 2016 | 281 | 0.520 |
Why?
|
| Mice | 67 | 2023 | 81539 | 0.520 |
Why?
|
| Simplexvirus | 6 | 2002 | 803 | 0.520 |
Why?
|
| Cell Transplantation | 10 | 2008 | 472 | 0.520 |
Why?
|
| Acetylcholinesterase | 11 | 2003 | 156 | 0.520 |
Why?
|
| Alzheimer Disease | 12 | 2022 | 8601 | 0.520 |
Why?
|
| Nervous System Diseases | 6 | 2024 | 1667 | 0.510 |
Why?
|
| Aging | 11 | 2021 | 8710 | 0.490 |
Why?
|
| Complement C1q | 1 | 2015 | 93 | 0.490 |
Why?
|
| Nerve Growth Factor | 5 | 2010 | 158 | 0.480 |
Why?
|
| Poly I-C | 2 | 2015 | 112 | 0.480 |
Why?
|
| Caudate Nucleus | 9 | 2016 | 390 | 0.470 |
Why?
|
| Inositol | 1 | 2015 | 215 | 0.470 |
Why?
|
| Amyotrophic Lateral Sclerosis | 4 | 2017 | 1469 | 0.470 |
Why?
|
| Synapsins | 1 | 2014 | 43 | 0.470 |
Why?
|
| Neurotoxins | 8 | 1995 | 240 | 0.460 |
Why?
|
| Multienzyme Complexes | 5 | 2004 | 666 | 0.460 |
Why?
|
| Calcium Signaling | 1 | 2018 | 733 | 0.460 |
Why?
|
| Genetic Vectors | 13 | 2016 | 3396 | 0.450 |
Why?
|
| Cells, Cultured | 28 | 2018 | 18966 | 0.450 |
Why?
|
| Transgenes | 4 | 2014 | 1010 | 0.450 |
Why?
|
| Gene Transfer Techniques | 8 | 2014 | 1206 | 0.450 |
Why?
|
| Quinolinic Acid | 8 | 2007 | 67 | 0.440 |
Why?
|
| Green Fluorescent Proteins | 6 | 2014 | 2065 | 0.440 |
Why?
|
| Motor Activity | 17 | 2016 | 2715 | 0.430 |
Why?
|
| Gene Expression Regulation | 11 | 2019 | 11904 | 0.430 |
Why?
|
| Neuroepithelial Cells | 3 | 2008 | 23 | 0.430 |
Why?
|
| Cell Survival | 21 | 2010 | 5791 | 0.430 |
Why?
|
| N-Methylaspartate | 7 | 1993 | 231 | 0.430 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 4 | 2014 | 415 | 0.430 |
Why?
|
| Brain-Derived Neurotrophic Factor | 8 | 2016 | 602 | 0.420 |
Why?
|
| Immunohistochemistry | 34 | 2012 | 11076 | 0.420 |
Why?
|
| Immunotoxins | 4 | 2001 | 175 | 0.420 |
Why?
|
| Triglycerides | 1 | 2020 | 2461 | 0.410 |
Why?
|
| Models, Neurological | 4 | 2016 | 1769 | 0.410 |
Why?
|
| Inflammation | 4 | 2019 | 10774 | 0.410 |
Why?
|
| Mice, Transgenic | 14 | 2018 | 9542 | 0.400 |
Why?
|
| Mitochondria | 6 | 2019 | 3624 | 0.400 |
Why?
|
| Septum Pellucidum | 4 | 1999 | 54 | 0.400 |
Why?
|
| Spinal Cord | 5 | 2014 | 1819 | 0.400 |
Why?
|
| Membrane Glycoproteins | 5 | 2020 | 3701 | 0.400 |
Why?
|
| Ibotenic Acid | 20 | 1992 | 59 | 0.390 |
Why?
|
| Acetylcholine | 4 | 2002 | 629 | 0.390 |
Why?
|
| Growth Substances | 4 | 2005 | 768 | 0.390 |
Why?
|
| Transcription Factors | 10 | 2015 | 12130 | 0.390 |
Why?
|
| Humans | 130 | 2024 | 761596 | 0.390 |
Why?
|
| Carrier Proteins | 4 | 2010 | 4937 | 0.390 |
Why?
|
| Cell Line | 25 | 2015 | 15601 | 0.390 |
Why?
|
| Fucosyltransferases | 2 | 2009 | 117 | 0.380 |
Why?
|
| Astrocytes | 5 | 2020 | 1346 | 0.380 |
Why?
|
| Maze Learning | 6 | 2005 | 483 | 0.380 |
Why?
|
| Otx Transcription Factors | 2 | 2010 | 42 | 0.370 |
Why?
|
| Pyridines | 4 | 2015 | 2875 | 0.370 |
Why?
|
| Fibroblast Growth Factor 8 | 2 | 2010 | 62 | 0.370 |
Why?
|
| Cocaine | 7 | 2004 | 958 | 0.370 |
Why?
|
| Axonal Transport | 6 | 2015 | 178 | 0.370 |
Why?
|
| Synucleins | 1 | 2010 | 108 | 0.360 |
Why?
|
| Cerebral Cortex | 14 | 2015 | 5779 | 0.360 |
Why?
|
| Neural Stem Cells | 2 | 2015 | 888 | 0.360 |
Why?
|
| Autophagy | 2 | 2015 | 1327 | 0.350 |
Why?
|
| Adenoviridae | 2 | 2014 | 1085 | 0.350 |
Why?
|
| Protein Isoforms | 2 | 2016 | 1699 | 0.350 |
Why?
|
| Receptors, Muscarinic | 2 | 2002 | 157 | 0.350 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2011 | 223 | 0.350 |
Why?
|
| Propionates | 5 | 2007 | 183 | 0.350 |
Why?
|
| rab3 GTP-Binding Proteins | 1 | 2009 | 29 | 0.350 |
Why?
|
| Promoter Regions, Genetic | 11 | 2016 | 5790 | 0.340 |
Why?
|
| Dopamine and cAMP-Regulated Phosphoprotein 32 | 3 | 2014 | 29 | 0.340 |
Why?
|
| Choline O-Acetyltransferase | 7 | 2005 | 156 | 0.330 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2012 | 269 | 0.330 |
Why?
|
| Fibroblast Growth Factor 2 | 4 | 2008 | 592 | 0.320 |
Why?
|
| Antigens, Surface | 3 | 2019 | 1606 | 0.320 |
Why?
|
| Imidazoles | 1 | 2015 | 1180 | 0.320 |
Why?
|
| DNA-Binding Proteins | 9 | 2014 | 9610 | 0.320 |
Why?
|
| Apomorphine | 8 | 2008 | 149 | 0.310 |
Why?
|
| Tretinoin | 2 | 2010 | 519 | 0.310 |
Why?
|
| Oxidative Stress | 3 | 2018 | 3113 | 0.310 |
Why?
|
| Electron Transport Complex III | 1 | 2008 | 31 | 0.310 |
Why?
|
| Electron Transport Complex II | 1 | 2008 | 53 | 0.310 |
Why?
|
| Cysteine Endopeptidases | 5 | 2004 | 551 | 0.310 |
Why?
|
| Neuritis | 1 | 2008 | 36 | 0.310 |
Why?
|
| N-Glycosyl Hydrolases | 4 | 2001 | 68 | 0.290 |
Why?
|
| Neuroprotective Agents | 7 | 2016 | 957 | 0.280 |
Why?
|
| Hedgehog Proteins | 3 | 2010 | 768 | 0.280 |
Why?
|
| Tetrahydronaphthalenes | 1 | 2007 | 86 | 0.280 |
Why?
|
| Fetal Stem Cells | 1 | 2006 | 10 | 0.270 |
Why?
|
| Muscarinic Agonists | 3 | 2005 | 91 | 0.270 |
Why?
|
| Receptors, Dopamine D3 | 1 | 2007 | 108 | 0.270 |
Why?
|
| Neuroglia | 6 | 2008 | 956 | 0.270 |
Why?
|
| Female | 83 | 2021 | 392705 | 0.270 |
Why?
|
| Papio | 8 | 1992 | 669 | 0.270 |
Why?
|
| Alternative Splicing | 1 | 2011 | 1093 | 0.270 |
Why?
|
| Rats, Inbred Strains | 27 | 1992 | 2088 | 0.270 |
Why?
|
| Nervous System | 2 | 2002 | 545 | 0.260 |
Why?
|
| Oligonucleotides, Antisense | 3 | 2019 | 461 | 0.260 |
Why?
|
| Gene Expression Profiling | 6 | 2015 | 9420 | 0.260 |
Why?
|
| Gastrointestinal Tract | 1 | 2012 | 833 | 0.260 |
Why?
|
| Amphetamine | 8 | 2008 | 224 | 0.260 |
Why?
|
| Homeodomain Proteins | 4 | 2009 | 2418 | 0.260 |
Why?
|
| Urinary Bladder | 1 | 2012 | 1152 | 0.260 |
Why?
|
| Receptors, Dopamine | 5 | 2004 | 296 | 0.260 |
Why?
|
| Brain Chemistry | 4 | 2005 | 960 | 0.250 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2007 | 329 | 0.250 |
Why?
|
| Male | 73 | 2021 | 360846 | 0.250 |
Why?
|
| Membrane Proteins | 5 | 2014 | 7859 | 0.250 |
Why?
|
| Injections, Intraventricular | 3 | 2014 | 225 | 0.250 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2006 | 2805 | 0.250 |
Why?
|
| Selection, Genetic | 1 | 2010 | 868 | 0.250 |
Why?
|
| Transplants | 2 | 2007 | 206 | 0.250 |
Why?
|
| Mice, Inbred C57BL | 18 | 2020 | 22174 | 0.240 |
Why?
|
| Sympatholytics | 4 | 2008 | 82 | 0.240 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 2417 | 0.240 |
Why?
|
| Swine | 14 | 2003 | 5915 | 0.240 |
Why?
|
| Germ Layers | 1 | 2005 | 72 | 0.240 |
Why?
|
| Synaptic Transmission | 3 | 2015 | 1173 | 0.240 |
Why?
|
| Telencephalon | 3 | 1994 | 142 | 0.240 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 2693 | 0.240 |
Why?
|
| Herbicides | 1 | 2005 | 105 | 0.240 |
Why?
|
| Growth Cones | 2 | 2005 | 117 | 0.230 |
Why?
|
| Mice, Inbred DBA | 2 | 2018 | 621 | 0.230 |
Why?
|
| Gene Expression | 10 | 2015 | 7581 | 0.230 |
Why?
|
| Transfection | 11 | 2014 | 5774 | 0.230 |
Why?
|
| Leupeptins | 3 | 2009 | 113 | 0.230 |
Why?
|
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 4 | 2016 | 61 | 0.230 |
Why?
|
| Cell Separation | 4 | 2009 | 1720 | 0.220 |
Why?
|
| Frontal Lobe | 1 | 2010 | 1420 | 0.220 |
Why?
|
| Afferent Pathways | 4 | 1999 | 298 | 0.210 |
Why?
|
| Cell Death | 7 | 2009 | 1679 | 0.210 |
Why?
|
| Blotting, Western | 8 | 2011 | 5035 | 0.210 |
Why?
|
| Mutation | 11 | 2023 | 30053 | 0.210 |
Why?
|
| Cell Count | 8 | 2014 | 1835 | 0.210 |
Why?
|
| Blood-Brain Barrier | 1 | 2009 | 1027 | 0.210 |
Why?
|
| Movement Disorders | 4 | 2014 | 459 | 0.210 |
Why?
|
| Gaucher Disease | 1 | 2023 | 110 | 0.200 |
Why?
|
| Cell Culture Techniques | 7 | 2010 | 1668 | 0.200 |
Why?
|
| Receptors, Dopamine D1 | 3 | 2009 | 293 | 0.200 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 999 | 0.200 |
Why?
|
| Epidermal Growth Factor | 1 | 2005 | 702 | 0.200 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2006 | 1651 | 0.200 |
Why?
|
| Tegmentum Mesencephali | 1 | 2001 | 59 | 0.190 |
Why?
|
| Neural Pathways | 9 | 2009 | 3060 | 0.190 |
Why?
|
| Avian Proteins | 1 | 2002 | 80 | 0.190 |
Why?
|
| Fluorescent Antibody Technique | 6 | 2011 | 2467 | 0.190 |
Why?
|
| Muscle Proteins | 1 | 2007 | 1154 | 0.190 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2006 | 842 | 0.190 |
Why?
|
| Cell Proliferation | 8 | 2012 | 10451 | 0.190 |
Why?
|
| Lipids | 3 | 2022 | 3341 | 0.190 |
Why?
|
| Nitro Compounds | 5 | 2007 | 74 | 0.190 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2021 | 79 | 0.190 |
Why?
|
| Lewy Body Disease | 1 | 2023 | 252 | 0.180 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2020 | 44 | 0.180 |
Why?
|
| Serotonin | 5 | 2005 | 1041 | 0.180 |
Why?
|
| RNA, Messenger | 10 | 2016 | 12794 | 0.180 |
Why?
|
| Receptors, Glutamate | 4 | 2007 | 228 | 0.180 |
Why?
|
| Nuclear Proteins | 6 | 2008 | 5799 | 0.170 |
Why?
|
| Microdialysis | 4 | 2008 | 161 | 0.170 |
Why?
|
| Antigens, CD | 2 | 2019 | 4001 | 0.170 |
Why?
|
| Cell Membrane | 1 | 2009 | 3687 | 0.170 |
Why?
|
| Gangliosides | 2 | 2020 | 132 | 0.170 |
Why?
|
| Ribosome Inactivating Proteins, Type 1 | 4 | 2001 | 27 | 0.170 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 6 | 2009 | 895 | 0.170 |
Why?
|
| Wnt1 Protein | 2 | 2010 | 121 | 0.170 |
Why?
|
| Genes, Reporter | 5 | 2008 | 1529 | 0.170 |
Why?
|
| Glutamic Acid | 4 | 2014 | 1176 | 0.170 |
Why?
|
| Prosencephalon | 2 | 1999 | 305 | 0.160 |
Why?
|
| Recovery of Function | 2 | 2007 | 2979 | 0.160 |
Why?
|
| Trans-Activators | 3 | 2006 | 2856 | 0.160 |
Why?
|
| Secretogranin II | 1 | 2018 | 9 | 0.160 |
Why?
|
| Genes, bcl-2 | 1 | 1999 | 119 | 0.160 |
Why?
|
| Nerve Tissue | 4 | 1994 | 78 | 0.160 |
Why?
|
| Thapsigargin | 1 | 2018 | 102 | 0.160 |
Why?
|
| Neurology | 1 | 2007 | 780 | 0.160 |
Why?
|
| Up-Regulation | 6 | 2020 | 4125 | 0.160 |
Why?
|
| Flow Cytometry | 7 | 2019 | 5870 | 0.160 |
Why?
|
| Stereotyped Behavior | 3 | 2001 | 135 | 0.160 |
Why?
|
| RNA, Double-Stranded | 2 | 2023 | 294 | 0.160 |
Why?
|
| Cell Lineage | 4 | 2009 | 2557 | 0.160 |
Why?
|
| Protein Transport | 3 | 2021 | 1967 | 0.150 |
Why?
|
| Complement Activation | 2 | 2015 | 445 | 0.150 |
Why?
|
| Succinimides | 3 | 2005 | 81 | 0.150 |
Why?
|
| Kainic Acid | 6 | 1992 | 203 | 0.150 |
Why?
|
| Genetic Engineering | 5 | 2002 | 933 | 0.150 |
Why?
|
| Cell Movement | 4 | 2006 | 5205 | 0.150 |
Why?
|
| Glucosylceramides | 1 | 2018 | 28 | 0.150 |
Why?
|
| tau Proteins | 2 | 2019 | 2095 | 0.150 |
Why?
|
| Nerve Endings | 1 | 1998 | 105 | 0.150 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2018 | 53 | 0.150 |
Why?
|
| Down-Regulation | 2 | 2002 | 2919 | 0.150 |
Why?
|
| Superoxide Dismutase | 3 | 2010 | 594 | 0.150 |
Why?
|
| Encephalitis | 1 | 2002 | 440 | 0.150 |
Why?
|
| Polyubiquitin | 1 | 2018 | 68 | 0.150 |
Why?
|
| Thalamus | 5 | 1992 | 1047 | 0.150 |
Why?
|
| Apolipoproteins E | 1 | 2023 | 1443 | 0.150 |
Why?
|
| Receptors, Transferrin | 1 | 2019 | 291 | 0.150 |
Why?
|
| Transcriptional Activation | 2 | 2003 | 1756 | 0.150 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 6 | 2009 | 63 | 0.150 |
Why?
|
| Intermediate Filament Proteins | 3 | 2008 | 262 | 0.140 |
Why?
|
| Immunoglobulin Fab Fragments | 2 | 1996 | 445 | 0.140 |
Why?
|
| Receptor, Muscarinic M1 | 2 | 2010 | 25 | 0.140 |
Why?
|
| Cognition | 4 | 2005 | 6992 | 0.140 |
Why?
|
| Cerebellum | 2 | 2016 | 1501 | 0.140 |
Why?
|
| Stress, Physiological | 2 | 2015 | 1403 | 0.140 |
Why?
|
| Neural Cell Adhesion Molecules | 2 | 2007 | 122 | 0.140 |
Why?
|
| Blood Proteins | 1 | 2002 | 1173 | 0.140 |
Why?
|
| Ligands | 5 | 2002 | 3272 | 0.130 |
Why?
|
| beta-Galactosidase | 3 | 2001 | 574 | 0.130 |
Why?
|
| Mental Disorders | 2 | 2015 | 6845 | 0.130 |
Why?
|
| Receptors, Dopamine D2 | 3 | 2008 | 485 | 0.130 |
Why?
|
| Random Allocation | 2 | 2013 | 2395 | 0.130 |
Why?
|
| Valinomycin | 1 | 2015 | 17 | 0.130 |
Why?
|
| Estrogens | 1 | 2003 | 1522 | 0.130 |
Why?
|
| Benzodiazepinones | 1 | 2015 | 50 | 0.130 |
Why?
|
| Carbon Radioisotopes | 4 | 2002 | 561 | 0.130 |
Why?
|
| Caspases | 1 | 1999 | 879 | 0.130 |
Why?
|
| Memory, Short-Term | 1 | 2002 | 982 | 0.130 |
Why?
|
| Basal Ganglia Diseases | 2 | 1995 | 145 | 0.130 |
Why?
|
| Cholinergic Agents | 3 | 2001 | 96 | 0.130 |
Why?
|
| Cognition Disorders | 2 | 2001 | 3980 | 0.130 |
Why?
|
| Nerve Fibers | 3 | 1998 | 708 | 0.130 |
Why?
|
| Memory Disorders | 2 | 2002 | 1199 | 0.130 |
Why?
|
| Multipotent Stem Cells | 2 | 2007 | 200 | 0.120 |
Why?
|
| Central Nervous System Diseases | 1 | 2000 | 520 | 0.120 |
Why?
|
| Nerve Net | 2 | 2024 | 2291 | 0.120 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2015 | 1899 | 0.120 |
Why?
|
| Time Factors | 10 | 2014 | 39969 | 0.120 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2009 | 3612 | 0.120 |
Why?
|
| Hydroxydopamines | 5 | 2008 | 59 | 0.120 |
Why?
|
| Animals, Newborn | 2 | 2014 | 2677 | 0.120 |
Why?
|
| Amyloid | 1 | 2000 | 841 | 0.120 |
Why?
|
| Blastocyst | 1 | 1998 | 433 | 0.120 |
Why?
|
| Space Perception | 2 | 2002 | 465 | 0.120 |
Why?
|
| Methylprednisolone Hemisuccinate | 1 | 1994 | 8 | 0.120 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2015 | 295 | 0.120 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 2 | 2005 | 144 | 0.120 |
Why?
|
| Case-Control Studies | 3 | 2021 | 22176 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2001 | 1406 | 0.110 |
Why?
|
| Catalase | 1 | 1994 | 218 | 0.110 |
Why?
|
| Targeted Gene Repair | 1 | 2013 | 20 | 0.110 |
Why?
|
| Antigens, Neoplasm | 1 | 2002 | 1993 | 0.110 |
Why?
|
| Mitosis | 2 | 2010 | 1188 | 0.110 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 1993 | 70 | 0.110 |
Why?
|
| Chromans | 1 | 1994 | 117 | 0.110 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 2 | 2010 | 64 | 0.110 |
Why?
|
| Fetus | 10 | 2001 | 1863 | 0.110 |
Why?
|
| Brain Diseases | 10 | 1990 | 1546 | 0.110 |
Why?
|
| Vimentin | 1 | 2014 | 255 | 0.110 |
Why?
|
| Proteins | 2 | 2015 | 6032 | 0.110 |
Why?
|
| Positron-Emission Tomography | 5 | 2008 | 6484 | 0.110 |
Why?
|
| Phenotype | 6 | 2010 | 16592 | 0.110 |
Why?
|
| Free Radical Scavengers | 1 | 1994 | 211 | 0.110 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 2 | 2005 | 66 | 0.110 |
Why?
|
| Escape Reaction | 2 | 2005 | 57 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2005 | 3617 | 0.100 |
Why?
|
| Endoplasmic Reticulum | 1 | 2018 | 1134 | 0.100 |
Why?
|
| Teratoma | 2 | 2006 | 404 | 0.100 |
Why?
|
| Kynurenic Acid | 1 | 1992 | 44 | 0.100 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2013 | 150 | 0.100 |
Why?
|
| Models, Biological | 4 | 2016 | 9469 | 0.100 |
Why?
|
| Radioligand Assay | 3 | 2009 | 366 | 0.100 |
Why?
|
| Lisuride | 1 | 1992 | 3 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 5 | 2003 | 9177 | 0.100 |
Why?
|
| Dihydroxyphenylalanine | 1 | 1992 | 74 | 0.100 |
Why?
|
| Major Histocompatibility Complex | 1 | 1995 | 870 | 0.100 |
Why?
|
| Tyrosine | 1 | 1996 | 1440 | 0.100 |
Why?
|
| Heat-Shock Proteins | 2 | 1993 | 795 | 0.100 |
Why?
|
| Parasympathomimetics | 3 | 2002 | 27 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2009 | 36426 | 0.100 |
Why?
|
| Mice, Knockout | 6 | 2014 | 14417 | 0.100 |
Why?
|
| Aged | 14 | 2021 | 169310 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2007 | 3733 | 0.100 |
Why?
|
| Tissue Banks | 1 | 2012 | 184 | 0.100 |
Why?
|
| Autoantigens | 1 | 2016 | 891 | 0.100 |
Why?
|
| Brain Mapping | 2 | 2004 | 6635 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2007 | 3429 | 0.090 |
Why?
|
| Primates | 1 | 2014 | 523 | 0.090 |
Why?
|
| Quinolinic Acids | 1 | 1991 | 15 | 0.090 |
Why?
|
| Quisqualic Acid | 1 | 1991 | 35 | 0.090 |
Why?
|
| Corpus Callosum | 2 | 1993 | 751 | 0.090 |
Why?
|
| Visual Cortex | 1 | 1999 | 1108 | 0.090 |
Why?
|
| Protein Kinases | 2 | 2015 | 1608 | 0.090 |
Why?
|
| Lentivirus | 2 | 2007 | 508 | 0.090 |
Why?
|
| Histocytochemistry | 7 | 1993 | 698 | 0.090 |
Why?
|
| Guanine Deaminase | 1 | 2010 | 2 | 0.090 |
Why?
|
| Lewy Bodies | 2 | 2009 | 145 | 0.090 |
Why?
|
| Ubiquinone | 1 | 2012 | 183 | 0.090 |
Why?
|
| Cerebrovascular Circulation | 3 | 2007 | 2727 | 0.090 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 2010 | 113 | 0.090 |
Why?
|
| Transduction, Genetic | 2 | 2007 | 903 | 0.090 |
Why?
|
| Hydrogen Peroxide | 1 | 2014 | 730 | 0.090 |
Why?
|
| Microfilament Proteins | 1 | 2016 | 1134 | 0.090 |
Why?
|
| Rats, Transgenic | 1 | 2010 | 69 | 0.090 |
Why?
|
| Skin | 1 | 2004 | 4484 | 0.090 |
Why?
|
| Cyclosporine | 3 | 2000 | 778 | 0.090 |
Why?
|
| Binding, Competitive | 2 | 2003 | 1141 | 0.090 |
Why?
|
| Sirolimus | 2 | 2012 | 1533 | 0.090 |
Why?
|
| Health | 1 | 1993 | 398 | 0.090 |
Why?
|
| Tissue Distribution | 1 | 2014 | 2264 | 0.090 |
Why?
|
| Cranial Nerves | 1 | 2010 | 98 | 0.090 |
Why?
|
| Discrimination Learning | 1 | 1991 | 278 | 0.090 |
Why?
|
| Tissue Transplantation | 1 | 2010 | 128 | 0.090 |
Why?
|
| Rats, Inbred F344 | 2 | 2002 | 826 | 0.090 |
Why?
|
| Receptors, Cholinergic | 2 | 2002 | 244 | 0.090 |
Why?
|
| Growth Inhibitors | 2 | 2005 | 378 | 0.090 |
Why?
|
| Middle Aged | 12 | 2021 | 220921 | 0.080 |
Why?
|
| Enkephalins | 2 | 2008 | 139 | 0.080 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1996 | 1349 | 0.080 |
Why?
|
| Norepinephrine | 3 | 2002 | 897 | 0.080 |
Why?
|
| Mutation, Missense | 1 | 2018 | 2571 | 0.080 |
Why?
|
| Analysis of Variance | 4 | 2005 | 6228 | 0.080 |
Why?
|
| Aldehyde Dehydrogenase | 3 | 2005 | 146 | 0.080 |
Why?
|
| Deoxyglucose | 3 | 2001 | 333 | 0.080 |
Why?
|
| Receptors, Immunologic | 2 | 2006 | 1410 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 6214 | 0.080 |
Why?
|
| Genes, Bacterial | 1 | 1992 | 1073 | 0.080 |
Why?
|
| Cyclosporins | 1 | 1989 | 216 | 0.080 |
Why?
|
| Dopamine beta-Hydroxylase | 3 | 2003 | 74 | 0.080 |
Why?
|
| Parthenogenesis | 1 | 2008 | 30 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2014 | 988 | 0.080 |
Why?
|
| Staining and Labeling | 2 | 2007 | 1085 | 0.080 |
Why?
|
| Ventral Tegmental Area | 1 | 2009 | 136 | 0.080 |
Why?
|
| Recombinant Proteins | 2 | 2008 | 6534 | 0.080 |
Why?
|
| Synaptic Vesicles | 1 | 2009 | 190 | 0.080 |
Why?
|
| Phenols | 1 | 2012 | 517 | 0.080 |
Why?
|
| Haplotypes | 2 | 2016 | 2713 | 0.080 |
Why?
|
| Receptors, Cell Surface | 3 | 2006 | 2822 | 0.080 |
Why?
|
| Animals, Genetically Modified | 4 | 2013 | 1561 | 0.080 |
Why?
|
| DNA, Mitochondrial | 1 | 2013 | 865 | 0.080 |
Why?
|
| Coculture Techniques | 3 | 2006 | 1341 | 0.080 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 58984 | 0.070 |
Why?
|
| Adenosine Triphosphate | 1 | 1994 | 1989 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2009 | 2872 | 0.070 |
Why?
|
| Receptors, Opioid | 1 | 2008 | 145 | 0.070 |
Why?
|
| Age Factors | 7 | 2014 | 18399 | 0.070 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2008 | 283 | 0.070 |
Why?
|
| Oligodendroglia | 2 | 2008 | 538 | 0.070 |
Why?
|
| Signal Transduction | 7 | 2016 | 23447 | 0.070 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1987 | 174 | 0.070 |
Why?
|
| Mice, Inbred NOD | 1 | 2011 | 1827 | 0.070 |
Why?
|
| Apoptosis | 2 | 2002 | 9490 | 0.070 |
Why?
|
| Fas Ligand Protein | 1 | 2007 | 216 | 0.070 |
Why?
|
| Autoradiography | 3 | 2001 | 728 | 0.070 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2008 | 195 | 0.070 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2008 | 299 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2014 | 10766 | 0.070 |
Why?
|
| Ubiquitins | 2 | 2001 | 366 | 0.070 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2010 | 620 | 0.070 |
Why?
|
| Retroviridae | 2 | 2000 | 850 | 0.070 |
Why?
|
| Mice, SCID | 1 | 2011 | 2626 | 0.070 |
Why?
|
| Complement C5 | 2 | 2003 | 103 | 0.070 |
Why?
|
| Totipotent Stem Cells | 1 | 2005 | 16 | 0.070 |
Why?
|
| Treatment Outcome | 6 | 2016 | 64685 | 0.060 |
Why?
|
| Gadolinium DTPA | 1 | 2009 | 823 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 1996 | 3208 | 0.060 |
Why?
|
| Neuroimmunomodulation | 1 | 2008 | 182 | 0.060 |
Why?
|
| Dopamine Agonists | 2 | 2014 | 352 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 1994 | 2448 | 0.060 |
Why?
|
| High Mobility Group Proteins | 1 | 2006 | 177 | 0.060 |
Why?
|
| Lymphokines | 2 | 2001 | 927 | 0.060 |
Why?
|
| Striatonigral Degeneration | 2 | 2002 | 13 | 0.060 |
Why?
|
| Placebo Effect | 1 | 2009 | 518 | 0.060 |
Why?
|
| Gliosis | 2 | 2007 | 245 | 0.060 |
Why?
|
| Oxazoles | 1 | 1987 | 199 | 0.060 |
Why?
|
| Protein Phosphatase 2 | 1 | 2007 | 231 | 0.060 |
Why?
|
| Dendritic Spines | 1 | 2007 | 243 | 0.060 |
Why?
|
| Dementia | 1 | 2000 | 2689 | 0.060 |
Why?
|
| PC12 Cells | 1 | 2005 | 317 | 0.060 |
Why?
|
| Ectoderm | 1 | 2005 | 137 | 0.060 |
Why?
|
| Embryonic Induction | 1 | 2005 | 151 | 0.060 |
Why?
|
| Molecular Sequence Data | 4 | 2011 | 17635 | 0.060 |
Why?
|
| Rotation | 3 | 1997 | 517 | 0.060 |
Why?
|
| Drug Administration Routes | 1 | 2004 | 150 | 0.060 |
Why?
|
| Neprilysin | 1 | 2007 | 478 | 0.060 |
Why?
|
| Cell Communication | 2 | 2008 | 1657 | 0.060 |
Why?
|
| Protein Precursors | 1 | 2008 | 1132 | 0.060 |
Why?
|
| Bromodeoxyuridine | 1 | 2004 | 311 | 0.060 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 2 | 2014 | 55 | 0.060 |
Why?
|
| Blotting, Northern | 2 | 1996 | 1545 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2008 | 718 | 0.060 |
Why?
|
| Adrenergic Agents | 2 | 2002 | 74 | 0.060 |
Why?
|
| RNA Interference | 2 | 2016 | 2832 | 0.060 |
Why?
|
| Indoles | 1 | 2012 | 1833 | 0.060 |
Why?
|
| Smad4 Protein | 1 | 2005 | 191 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2007 | 3810 | 0.060 |
Why?
|
| Risk Factors | 6 | 2019 | 74213 | 0.060 |
Why?
|
| DNA Damage | 1 | 2013 | 2449 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 3 | 2007 | 2645 | 0.060 |
Why?
|
| Acid Ceramidase | 1 | 2023 | 21 | 0.060 |
Why?
|
| Glucose | 3 | 2003 | 4347 | 0.050 |
Why?
|
| Lateral Ventricles | 1 | 2004 | 146 | 0.050 |
Why?
|
| Introns | 1 | 2006 | 981 | 0.050 |
Why?
|
| Mice, Inbred Strains | 2 | 1997 | 1762 | 0.050 |
Why?
|
| DNA Footprinting | 1 | 2003 | 97 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2015 | 3028 | 0.050 |
Why?
|
| Piperazines | 1 | 1994 | 2523 | 0.050 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2003 | 107 | 0.050 |
Why?
|
| Narcotic Antagonists | 1 | 2008 | 585 | 0.050 |
Why?
|
| Dopamine Uptake Inhibitors | 3 | 1999 | 297 | 0.050 |
Why?
|
| Plaque, Amyloid | 1 | 2007 | 760 | 0.050 |
Why?
|
| Complement Inactivator Proteins | 1 | 2002 | 74 | 0.050 |
Why?
|
| Globus Pallidus | 4 | 1988 | 250 | 0.050 |
Why?
|
| Macaca mulatta | 2 | 2003 | 2329 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 6075 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2003 | 1693 | 0.050 |
Why?
|
| Vero Cells | 2 | 2002 | 482 | 0.050 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2003 | 293 | 0.050 |
Why?
|
| Carcinoma | 1 | 2014 | 2330 | 0.050 |
Why?
|
| Environment, Controlled | 1 | 2002 | 42 | 0.050 |
Why?
|
| Peptide Hydrolases | 2 | 2003 | 624 | 0.050 |
Why?
|
| Oxygen Consumption | 2 | 2003 | 1866 | 0.050 |
Why?
|
| Fibroblast Growth Factors | 1 | 2008 | 867 | 0.050 |
Why?
|
| Neurotransmitter Agents | 2 | 2018 | 665 | 0.050 |
Why?
|
| Energy Metabolism | 3 | 2003 | 2882 | 0.050 |
Why?
|
| Protein Subunits | 2 | 2003 | 943 | 0.050 |
Why?
|
| Clinical Trials as Topic | 4 | 2012 | 8002 | 0.050 |
Why?
|
| Doxycycline | 1 | 2004 | 344 | 0.050 |
Why?
|
| Memory | 1 | 1991 | 2193 | 0.050 |
Why?
|
| Glutamates | 2 | 1994 | 389 | 0.050 |
Why?
|
| Mesoderm | 1 | 2005 | 674 | 0.050 |
Why?
|
| Receptors, Nerve Growth Factor | 2 | 2001 | 198 | 0.050 |
Why?
|
| Response Elements | 1 | 2003 | 309 | 0.050 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2001 | 48 | 0.050 |
Why?
|
| Atropine | 1 | 2002 | 244 | 0.050 |
Why?
|
| Complement C3 | 1 | 2023 | 435 | 0.050 |
Why?
|
| gamma-Aminobutyric Acid | 5 | 1996 | 1141 | 0.050 |
Why?
|
| Trisomy | 1 | 2003 | 260 | 0.050 |
Why?
|
| Receptors, Adrenergic | 1 | 2001 | 155 | 0.050 |
Why?
|
| Virus Assembly | 1 | 2002 | 139 | 0.050 |
Why?
|
| Autopsy | 1 | 2005 | 1009 | 0.050 |
Why?
|
| Muscarinic Antagonists | 1 | 2002 | 135 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 16990 | 0.050 |
Why?
|
| Acetylcysteine | 1 | 2002 | 260 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2008 | 1787 | 0.050 |
Why?
|
| Sandhoff Disease | 1 | 2020 | 14 | 0.050 |
Why?
|
| Microinjections | 2 | 2004 | 321 | 0.040 |
Why?
|
| Adult | 7 | 2019 | 221210 | 0.040 |
Why?
|
| Structure-Activity Relationship | 2 | 2003 | 3076 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2020 | 41495 | 0.040 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2001 | 186 | 0.040 |
Why?
|
| Escherichia coli | 1 | 1992 | 4217 | 0.040 |
Why?
|
| Isoquinolines | 1 | 2002 | 352 | 0.040 |
Why?
|
| Pregnancy | 5 | 2007 | 29890 | 0.040 |
Why?
|
| Long-Term Potentiation | 1 | 2002 | 293 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2008 | 2206 | 0.040 |
Why?
|
| Dendrites | 1 | 2003 | 475 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2011 | 13446 | 0.040 |
Why?
|
| Glutamate Decarboxylase | 3 | 1992 | 239 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2004 | 6345 | 0.040 |
Why?
|
| Human Genome Project | 1 | 2000 | 200 | 0.040 |
Why?
|
| Denervation | 1 | 2001 | 265 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2003 | 3094 | 0.040 |
Why?
|
| Stereotaxic Techniques | 2 | 1993 | 555 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2016 | 15936 | 0.040 |
Why?
|
| Thymidine Kinase | 2 | 1997 | 286 | 0.040 |
Why?
|
| Transcription, Genetic | 3 | 2010 | 7593 | 0.040 |
Why?
|
| beta Catenin | 1 | 2004 | 1040 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2001 | 748 | 0.040 |
Why?
|
| Immunosuppressive Agents | 2 | 2005 | 4176 | 0.040 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2000 | 194 | 0.040 |
Why?
|
| Hydrolases | 1 | 2019 | 147 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2004 | 1342 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2007 | 4576 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2003 | 1494 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2005 | 1601 | 0.040 |
Why?
|
| Reaction Time | 1 | 2005 | 2089 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2009 | 1868 | 0.040 |
Why?
|
| Homeostasis | 1 | 2009 | 3323 | 0.040 |
Why?
|
| Endothelial Growth Factors | 1 | 2001 | 673 | 0.040 |
Why?
|
| Haplorhini | 1 | 1999 | 525 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 1999 | 750 | 0.040 |
Why?
|
| Locomotion | 2 | 2013 | 388 | 0.040 |
Why?
|
| Drug Delivery Systems | 2 | 2000 | 2226 | 0.040 |
Why?
|
| Environment | 1 | 2004 | 1123 | 0.040 |
Why?
|
| Antirheumatic Agents | 1 | 2008 | 1373 | 0.040 |
Why?
|
| Chimera | 1 | 1999 | 453 | 0.040 |
Why?
|
| Biogenic Monoamines | 1 | 1998 | 50 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2007 | 1898 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2003 | 1526 | 0.040 |
Why?
|
| Lactates | 1 | 1998 | 405 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2003 | 1035 | 0.040 |
Why?
|
| Transplantation, Heterotopic | 1 | 1998 | 174 | 0.040 |
Why?
|
| Dentate Gyrus | 1 | 1999 | 164 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2003 | 1076 | 0.040 |
Why?
|
| Piperidines | 2 | 2008 | 1656 | 0.040 |
Why?
|
| Image Enhancement | 1 | 2008 | 2884 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2002 | 1416 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2005 | 1964 | 0.040 |
Why?
|
| Avoidance Learning | 1 | 1999 | 248 | 0.040 |
Why?
|
| Syndrome | 1 | 2023 | 3267 | 0.040 |
Why?
|
| Atrophy | 2 | 2014 | 1633 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3779 | 0.030 |
Why?
|
| Genetic Association Studies | 2 | 2016 | 2735 | 0.030 |
Why?
|
| Tacrolimus | 1 | 2000 | 733 | 0.030 |
Why?
|
| Cytokines | 2 | 2023 | 7396 | 0.030 |
Why?
|
| Neurons, Afferent | 2 | 1990 | 498 | 0.030 |
Why?
|
| Plant Proteins | 1 | 1999 | 370 | 0.030 |
Why?
|
| Rotarod Performance Test | 1 | 2016 | 63 | 0.030 |
Why?
|
| Extremities | 1 | 2001 | 867 | 0.030 |
Why?
|
| Pharmacogenetics | 1 | 2000 | 675 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 1989 | 553 | 0.030 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 1996 | 77 | 0.030 |
Why?
|
| Excitatory Amino Acids | 1 | 1995 | 17 | 0.030 |
Why?
|
| Head | 1 | 2001 | 924 | 0.030 |
Why?
|
| Electric Stimulation Therapy | 1 | 2001 | 628 | 0.030 |
Why?
|
| Thalamic Nuclei | 2 | 1993 | 111 | 0.030 |
Why?
|
| MyoD Protein | 1 | 1996 | 142 | 0.030 |
Why?
|
| Isoflavones | 1 | 2016 | 136 | 0.030 |
Why?
|
| Plasmids | 3 | 2009 | 2269 | 0.030 |
Why?
|
| Amidines | 1 | 1994 | 29 | 0.030 |
Why?
|
| Safety | 1 | 2000 | 1149 | 0.030 |
Why?
|
| Ganglia | 1 | 1995 | 87 | 0.030 |
Why?
|
| Peptide Elongation Factor 1 | 2 | 2007 | 39 | 0.030 |
Why?
|
| Receptors, AMPA | 2 | 1993 | 336 | 0.030 |
Why?
|
| Homovanillic Acid | 2 | 1992 | 75 | 0.030 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1996 | 251 | 0.030 |
Why?
|
| Species Specificity | 2 | 1990 | 2414 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2003 | 1250 | 0.030 |
Why?
|
| Base Sequence | 4 | 2006 | 12441 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2010 | 6567 | 0.030 |
Why?
|
| Brain Injuries | 1 | 2006 | 2054 | 0.030 |
Why?
|
| Excitatory Amino Acid Agents | 1 | 2014 | 23 | 0.030 |
Why?
|
| Efferent Pathways | 1 | 1994 | 165 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2007 | 5112 | 0.030 |
Why?
|
| Wakefulness | 1 | 2001 | 1265 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 17904 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2003 | 20100 | 0.030 |
Why?
|
| Monoamine Oxidase | 1 | 1994 | 181 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2000 | 1078 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1994 | 416 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 2057 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 1994 | 452 | 0.030 |
Why?
|
| Cyclic AMP | 2 | 2009 | 1463 | 0.030 |
Why?
|
| Neuronal Plasticity | 1 | 2002 | 1436 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 2009 | 1749 | 0.030 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 1993 | 127 | 0.030 |
Why?
|
| Receptor, trkB | 1 | 2014 | 124 | 0.030 |
Why?
|
| Ion Channels | 2 | 2000 | 1040 | 0.030 |
Why?
|
| Neurogenesis | 2 | 2012 | 863 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 802 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 1994 | 271 | 0.030 |
Why?
|
| Postoperative Period | 1 | 1998 | 1814 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 1993 | 397 | 0.030 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2014 | 369 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2014 | 421 | 0.030 |
Why?
|
| Dopamine Antagonists | 1 | 1993 | 288 | 0.030 |
Why?
|
| Septal Nuclei | 2 | 1990 | 85 | 0.030 |
Why?
|
| Bromine Radioisotopes | 1 | 1992 | 1 | 0.030 |
Why?
|
| Succinate Dehydrogenase | 1 | 1993 | 145 | 0.030 |
Why?
|
| Sympathectomy | 1 | 1992 | 72 | 0.030 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2014 | 324 | 0.030 |
Why?
|
| Benzazepines | 1 | 2014 | 310 | 0.020 |
Why?
|
| Oxygen | 1 | 2003 | 4227 | 0.020 |
Why?
|
| Luminescent Proteins | 2 | 2006 | 837 | 0.020 |
Why?
|
| Quinoxalines | 1 | 1993 | 296 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 1612 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 2013 | 579 | 0.020 |
Why?
|
| Habituation, Psychophysiologic | 1 | 1991 | 147 | 0.020 |
Why?
|
| Brain Neoplasms | 2 | 2006 | 9032 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2014 | 1090 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2003 | 4544 | 0.020 |
Why?
|
| Magnesium | 1 | 2014 | 804 | 0.020 |
Why?
|
| Stromal Cells | 2 | 2006 | 1330 | 0.020 |
Why?
|
| Injections | 1 | 1993 | 831 | 0.020 |
Why?
|
| Administration, Oral | 1 | 1998 | 4021 | 0.020 |
Why?
|
| Diencephalon | 1 | 1990 | 54 | 0.020 |
Why?
|
| Thalamic Diseases | 1 | 1989 | 15 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 1996 | 2220 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1993 | 586 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2001 | 3492 | 0.020 |
Why?
|
| Gene Amplification | 1 | 1994 | 1089 | 0.020 |
Why?
|
| Ciliary Neurotrophic Factor | 2 | 2000 | 77 | 0.020 |
Why?
|
| Eye | 1 | 2013 | 712 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2005 | 3816 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2000 | 3713 | 0.020 |
Why?
|
| Lentivirus Infections | 1 | 2009 | 11 | 0.020 |
Why?
|
| Protein Binding | 3 | 2008 | 9353 | 0.020 |
Why?
|
| Access to Information | 1 | 2012 | 316 | 0.020 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2016 | 874 | 0.020 |
Why?
|
| Stilbamidines | 1 | 1989 | 43 | 0.020 |
Why?
|
| Immune System | 1 | 1994 | 796 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2014 | 1170 | 0.020 |
Why?
|
| Fluorine Radioisotopes | 1 | 1992 | 418 | 0.020 |
Why?
|
| Schwann Cells | 1 | 1989 | 197 | 0.020 |
Why?
|
| Gestational Age | 2 | 1996 | 3577 | 0.020 |
Why?
|
| Raphe Nuclei | 1 | 1988 | 103 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1998 | 3769 | 0.020 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 1989 | 140 | 0.020 |
Why?
|
| Submandibular Gland | 1 | 1988 | 87 | 0.020 |
Why?
|
| Choline | 1 | 1990 | 515 | 0.020 |
Why?
|
| Phosphoglycerate Kinase | 1 | 2007 | 66 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 2006 | 1991 | 0.020 |
Why?
|
| Hypoglossal Nerve | 1 | 1988 | 108 | 0.020 |
Why?
|
| Culture Techniques | 1 | 2008 | 531 | 0.020 |
Why?
|
| Biological Transport | 1 | 1992 | 2091 | 0.020 |
Why?
|
| Parasympathetic Nervous System | 1 | 1988 | 142 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2012 | 1186 | 0.020 |
Why?
|
| Heterozygote | 1 | 2014 | 2787 | 0.020 |
Why?
|
| Triiodothyronine | 1 | 1989 | 493 | 0.020 |
Why?
|
| Metabolome | 1 | 2014 | 989 | 0.020 |
Why?
|
| Antibodies | 1 | 1995 | 2418 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2001 | 12341 | 0.020 |
Why?
|
| Water Deprivation | 1 | 1986 | 19 | 0.020 |
Why?
|
| Caenorhabditis elegans | 1 | 2016 | 1456 | 0.020 |
Why?
|
| Immunochemistry | 1 | 1986 | 116 | 0.020 |
Why?
|
| Dystonia | 1 | 1990 | 370 | 0.020 |
Why?
|
| Dopa Decarboxylase | 1 | 2006 | 14 | 0.020 |
Why?
|
| Dynamins | 1 | 2007 | 139 | 0.020 |
Why?
|
| Retrograde Degeneration | 1 | 1986 | 8 | 0.020 |
Why?
|
| Genetic Markers | 1 | 1992 | 2601 | 0.020 |
Why?
|
| Drosophila | 1 | 2013 | 1495 | 0.020 |
Why?
|
| Vagus Nerve | 1 | 1988 | 458 | 0.020 |
Why?
|
| Cytological Techniques | 1 | 1988 | 218 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2006 | 777 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 1994 | 2139 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2007 | 740 | 0.020 |
Why?
|
| Light | 1 | 1991 | 1353 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2002 | 9001 | 0.020 |
Why?
|
| Cricetulus | 1 | 2007 | 814 | 0.020 |
Why?
|
| Water | 1 | 1991 | 1411 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2008 | 1262 | 0.020 |
Why?
|
| Family | 1 | 2016 | 3195 | 0.020 |
Why?
|
| Alleles | 1 | 2016 | 6864 | 0.010 |
Why?
|
| Motor Skills | 1 | 2008 | 521 | 0.010 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 695 | 0.010 |
Why?
|
| Reward | 1 | 1991 | 971 | 0.010 |
Why?
|
| CHO Cells | 1 | 2007 | 1387 | 0.010 |
Why?
|
| Image Cytometry | 1 | 2004 | 54 | 0.010 |
Why?
|
| Cholecystokinin | 1 | 1985 | 117 | 0.010 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2005 | 111 | 0.010 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2006 | 286 | 0.010 |
Why?
|
| DNA Repair | 1 | 2013 | 2046 | 0.010 |
Why?
|
| Wheat Germ Agglutinins | 3 | 1988 | 47 | 0.010 |
Why?
|
| Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate | 3 | 1988 | 35 | 0.010 |
Why?
|
| Kinetics | 1 | 1992 | 6374 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2007 | 1646 | 0.010 |
Why?
|
| Organ Specificity | 2 | 2003 | 1968 | 0.010 |
Why?
|
| Artifacts | 1 | 1992 | 1911 | 0.010 |
Why?
|
| Disease Progression | 1 | 2001 | 13510 | 0.010 |
Why?
|
| Horseradish Peroxidase | 3 | 1988 | 166 | 0.010 |
Why?
|
| Cricetinae | 1 | 2007 | 2423 | 0.010 |
Why?
|
| Lumbosacral Region | 1 | 2004 | 293 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 1992 | 2009 | 0.010 |
Why?
|
| Movement | 1 | 1990 | 1478 | 0.010 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2002 | 68 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2009 | 1971 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1998 | 9319 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 3801 | 0.010 |
Why?
|
| Endocytosis | 1 | 2007 | 957 | 0.010 |
Why?
|
| Benzimidazoles | 1 | 2008 | 858 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2012 | 3442 | 0.010 |
Why?
|
| Kidney | 1 | 1998 | 7048 | 0.010 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2002 | 188 | 0.010 |
Why?
|
| Basal Ganglia | 1 | 1985 | 554 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 1997 | 14665 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2000 | 7406 | 0.010 |
Why?
|
| Genes, Immediate-Early | 1 | 2002 | 102 | 0.010 |
Why?
|
| STAT3 Transcription Factor | 1 | 2005 | 871 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 2002 | 462 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1996 | 4948 | 0.010 |
Why?
|
| Cryopreservation | 1 | 2006 | 728 | 0.010 |
Why?
|
| 5' Untranslated Regions | 1 | 2002 | 256 | 0.010 |
Why?
|
| Biopsy | 1 | 2012 | 6766 | 0.010 |
Why?
|
| Dimerization | 1 | 2002 | 891 | 0.010 |
Why?
|
| Sympathectomy, Chemical | 1 | 1999 | 25 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 3792 | 0.010 |
Why?
|
| Neck | 1 | 2004 | 734 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2012 | 3688 | 0.010 |
Why?
|
| Binding Sites | 2 | 2002 | 6056 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2002 | 13642 | 0.010 |
Why?
|
| Benzofurans | 2 | 1990 | 139 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2008 | 2650 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2002 | 790 | 0.010 |
Why?
|
| Learning | 1 | 2007 | 1740 | 0.010 |
Why?
|
| Brain Stem | 1 | 2002 | 858 | 0.010 |
Why?
|
| Cytomegalovirus | 1 | 2002 | 756 | 0.010 |
Why?
|
| Dextroamphetamine | 1 | 1997 | 134 | 0.010 |
Why?
|
| Fluorescent Dyes | 3 | 1990 | 1903 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2012 | 7968 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2003 | 3597 | 0.010 |
Why?
|
| Neoplastic Stem Cells | 1 | 2004 | 1351 | 0.010 |
Why?
|
| Substantia Innominata | 2 | 1986 | 23 | 0.010 |
Why?
|
| Models, Animal | 1 | 2003 | 2112 | 0.010 |
Why?
|
| Methamphetamine | 2 | 1988 | 165 | 0.010 |
Why?
|
| Attention | 1 | 1986 | 2396 | 0.010 |
Why?
|
| Wound Healing | 1 | 2006 | 2805 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 2000 | 783 | 0.010 |
Why?
|
| Microscopy, Electron | 2 | 1988 | 2561 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2005 | 8321 | 0.010 |
Why?
|
| Actins | 1 | 2002 | 2050 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 2007 | 3839 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2002 | 4807 | 0.010 |
Why?
|
| Mazindol | 1 | 1993 | 13 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 6131 | 0.010 |
Why?
|
| Research Design | 1 | 2009 | 6180 | 0.010 |
Why?
|
| Receptors, Amino Acid | 1 | 1993 | 30 | 0.010 |
Why?
|
| Receptors, Kainic Acid | 1 | 1993 | 91 | 0.010 |
Why?
|
| Zebrafish | 1 | 2002 | 3008 | 0.010 |
Why?
|
| Cell Division | 2 | 1989 | 4465 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1993 | 1900 | 0.010 |
Why?
|
| Phytohemagglutinins | 1 | 1989 | 167 | 0.010 |
Why?
|
| DNA Primers | 1 | 1993 | 2820 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1992 | 20568 | 0.000 |
Why?
|
| Rhodamines | 1 | 1988 | 178 | 0.000 |
Why?
|
| Muscimol | 1 | 1988 | 70 | 0.000 |
Why?
|
| Patient Selection | 1 | 2000 | 4244 | 0.000 |
Why?
|
| United States | 1 | 2016 | 72340 | 0.000 |
Why?
|
| Forelimb | 1 | 1988 | 116 | 0.000 |
Why?
|
| Migraine Disorders | 1 | 2000 | 1703 | 0.000 |
Why?
|
| Aspartic Acid | 1 | 1990 | 576 | 0.000 |
Why?
|
| Genetic Testing | 1 | 2000 | 3537 | 0.000 |
Why?
|
| Alkynes | 1 | 1988 | 320 | 0.000 |
Why?
|
| Catecholamines | 1 | 1988 | 386 | 0.000 |
Why?
|
| Dialysis | 1 | 1986 | 73 | 0.000 |
Why?
|
| Suspensions | 1 | 1986 | 66 | 0.000 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 1986 | 93 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2000 | 3415 | 0.000 |
Why?
|
| Tissue Preservation | 1 | 1985 | 174 | 0.000 |
Why?
|
| Colchicine | 1 | 1986 | 259 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2000 | 15266 | 0.000 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 1989 | 952 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 2006 | 15633 | 0.000 |
Why?
|
| Posture | 1 | 1988 | 957 | 0.000 |
Why?
|
| Perfusion | 1 | 1988 | 1373 | 0.000 |
Why?
|
| Retinal Ganglion Cells | 1 | 1989 | 811 | 0.000 |
Why?
|
| Hypertension | 1 | 2000 | 8540 | 0.000 |
Why?
|
| Psychomotor Performance | 1 | 1988 | 1882 | 0.000 |
Why?
|
| Embryo, Nonmammalian | 1 | 1983 | 906 | 0.000 |
Why?
|
| Functional Laterality | 1 | 1986 | 2257 | 0.000 |
Why?
|
| Obesity | 1 | 2000 | 12947 | 0.000 |
Why?
|
| Neoplasms | 1 | 2000 | 22173 | 0.000 |
Why?
|